{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:30:49Z","timestamp":1789137049589,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":449,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.1002\/ehf2.15166","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T02:40:31Z","timestamp":1732675231000},"page":"1529-1531","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing Diagnostics and Therapy in Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1093","volume":"12","author":[{"given":"Katarzyna","family":"Holcman","sequence":"first","affiliation":[{"name":"Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, St. John Paul II Hospital , Krakow ,","place":["Poland"]},{"name":"Department of Nuclear Medicine, St. John Paul II Hospital , Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-5432","authenticated-orcid":false,"given":"Micha\u0142","family":"Tkaczyszyn","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]},{"name":"Institute of Heart Diseases, University Hospital , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"2026021804240855800_ehf215166-bib-0001","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ehf2.13792","article-title":"Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis","volume":"9","author":"Zampiccoli","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0002","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ehf2.13847","article-title":"A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"9","author":"Nakashima","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0003","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ehf2.14337","article-title":"Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure","volume":"10","author":"Berthelot","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0004","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/ehf2.14350","article-title":"Health-related quality of life among transthyretin amyloid cardiomyopathy patients","volume":"10","author":"Eldhagen","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0005","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ehf2.14173","article-title":"Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS)","volume":"10","author":"Ladefoged","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0006","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1002\/ehf2.14517","article-title":"Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records","volume":"10","author":"Moya","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0007","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/ehf2.13913","article-title":"Healthcare resource use of patients with transthyretin amyloid cardiomyopathy","volume":"9","author":"Lauppe","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0008","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ehf2.13961","article-title":"Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries","volume":"9","author":"Lauppe","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0009","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/ehf2.14380","article-title":"Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy","volume":"10","author":"Takashio","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0010","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.33963\/v.kp.97648","article-title":"Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: a position statement of the Polish Cardiac Society","volume":"81","author":"Grzybowski","year":"2023","journal-title":"Kardiol Pol"},{"key":"2026021804240855800_ehf215166-bib-0011","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ehf2.13738","article-title":"Echocardiographic and clinical predictors of cardiac amyloidosis: limitations of apical sparing","volume":"9","author":"Kyrouac","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0012","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14971","article-title":"Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy","author":"Garcia-Pavia","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0013","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5603\/NMR.a2022.0033","article-title":"The scintigraphic diagnosis of cardiac amyloidosis. An expert opinion endorsed by the Section of Nuclear Medicine of the Polish Cardiac Society and the Polish Nuclear Medicine Society","volume":"25","author":"Holcman","year":"2022","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2026021804240855800_ehf215166-bib-0014","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ehf2.13693","article-title":"99mTechnetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy","volume":"9","author":"Tahara","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0015","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/ehf2.13884","article-title":"Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review","volume":"9","author":"Bay","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0016","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s10554-024-03158-z","article-title":"Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness","volume":"40","author":"Holcman","year":"2024","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026021804240855800_ehf215166-bib-0017","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1002\/ehf2.14164","article-title":"An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction","volume":"9","author":"Yang","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0018","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0019","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/ehf2.14000","article-title":"Incidence and predictors of worsening heart failure in patients with wild-type transthyretin cardiac amyloidosis","volume":"9","author":"Ladefoged","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0020","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/ehf2.13909","article-title":"Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis","volume":"9","author":"Oike","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0021","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ehf2.14188","article-title":"SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin","volume":"10","author":"Dobner","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0022","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ehf2.14262","article-title":"Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis","volume":"10","author":"Hoerbrand","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0023","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ehf2.13818","article-title":"Prevalence and determinants of iron deficiency in cardiac amyloidosis","volume":"9","author":"Jobb\u00e9-Duval","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0024","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ehf2.13701","article-title":"Thromboembolism and bleeding in systemic amyloidosis: a review","volume":"9","author":"Nicol","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026021804240855800_ehf215166-bib-0025","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/ehf2.13851","article-title":"Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis","volume":"9","author":"Papathanasiou","year":"2022","journal-title":"ESC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1529\/66955946\/eschf_12_3_1529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/3\/1529\/66955946\/eschf_12_3_1529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:24:12Z","timestamp":1771406652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/3\/1529\/8488311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,26]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15166","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"2024-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}